HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guo-Qiang Chen Selected Research

microthane foam

9/2009Characterization, biodegradability and blood compatibility of poly[(R)-3-hydroxybutyrate] based poly(ester-urethane)s.
1/2009Synthesis, characterization and cell compatibility of novel poly(ester urethane)s based on poly(3-hydroxybutyrate-co-4-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) prepared by melting polymerization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guo-Qiang Chen Research Topics

Disease

51Neoplasms (Cancer)
06/2022 - 11/2002
22Leukemia
01/2021 - 04/2002
17Hypoxia (Hypoxemia)
01/2022 - 07/2005
17Acute Promyelocytic Leukemia
01/2019 - 04/2002
11Neoplasm Metastasis (Metastasis)
01/2017 - 11/2006
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 05/2005
8Carcinogenesis
06/2022 - 07/2006
6Carcinoma (Carcinomatosis)
05/2013 - 11/2006
6Lymphatic Metastasis
02/2012 - 11/2006
5Stomach Neoplasms (Stomach Cancer)
12/2013 - 10/2003
4Hepatocellular Carcinoma (Hepatoma)
11/2020 - 12/2008
4Genetic Translocation (Chromosomal Translocation)
05/2007 - 11/2002
3Hypertension (High Blood Pressure)
01/2019 - 03/2006
3Genomic Instability
01/2018 - 12/2016
3Colonic Neoplasms (Colon Cancer)
11/2016 - 10/2008
3Colorectal Neoplasms (Colorectal Cancer)
08/2010 - 09/2009
3Suppuration
09/2009 - 01/2009
2COVID-19
10/2022 - 01/2021
2Inflammation (Inflammations)
12/2021 - 01/2021
2Colitis
12/2021 - 10/2021
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 12/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 02/2012
2Breast Neoplasms (Breast Cancer)
01/2018 - 01/2017
2Pathologic Processes
01/2018 - 01/2011
2Chromosome Aberrations (Chromosome Abnormalities)
12/2017 - 08/2006
2Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 01/2017
2Osteoporosis
12/2016 - 09/2014
2Prostatic Neoplasms (Prostate Cancer)
03/2014 - 01/2009
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2010 - 01/2005

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
06/2022 - 07/2005
11Pharmaceutical PreparationsIBA
01/2021 - 12/2004
9Messenger RNA (mRNA)IBA
01/2021 - 12/2005
9Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2019 - 05/2002
9Arsenic Trioxide (Trisenox)FDA Link
01/2019 - 04/2002
7DNA (Deoxyribonucleic Acid)IBA
11/2020 - 08/2007
6Phosphotransferases (Kinase)IBA
01/2018 - 05/2005
6EnzymesIBA
12/2017 - 05/2009
6Oxygen (Dioxygen)IBA
05/2013 - 06/2006
53-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA
12/2021 - 11/2005
5MicroRNAs (MicroRNA)IBA
01/2021 - 05/2011
5Transcription Factors (Transcription Factor)IBA
01/2017 - 12/2010
5NSC606985IBA
11/2009 - 05/2005
5CamptothecinIBA
11/2009 - 05/2005
4KetonesIBA
06/2022 - 09/2014
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2022 - 11/2015
4Retinoic Acid Receptor alphaIBA
01/2019 - 12/2010
4ChromatinIBA
11/2016 - 08/2009
4LuciferasesIBA
11/2016 - 08/2009
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014 - 01/2007
4Small Interfering RNA (siRNA)IBA
08/2010 - 10/2007
4cobaltous chloride (cobalt(II)chloride)IBA
10/2009 - 07/2005
3TensinsIBA
06/2022 - 11/2015
3LigandsIBA
01/2022 - 12/2008
3CateninsIBA
01/2018 - 11/2015
3PolyhydroxyalkanoatesIBA
09/2014 - 03/2011
3DiterpenesIBA
04/2012 - 07/2010
3CCAAT-Enhancer-Binding Protein-alphaIBA
10/2011 - 07/2005
3Deferoxamine (Desferal)FDA LinkGeneric
10/2009 - 07/2005
31,6-hexamethylene diisocyanate (hexamethylene diisocyanate)IBA
09/2009 - 01/2009
3poly(3- hydroxybutyrate- co- 3- hydroxyhexanoate)IBA
06/2009 - 01/2009
3promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
01/2006 - 11/2002
2Therapeutic UsesIBA
06/2022 - 09/2013
2ORALIT (ORS)IBA
01/2022 - 01/2021
2Dextran SulfateIBA
12/2021 - 10/2021
2CalciumIBA
01/2021 - 09/2014
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020 - 01/2020
2Fatty Acids (Saturated Fatty Acids)IBA
01/2019 - 03/2006
2AgarIBA
01/2018 - 01/2016
2RNA (Ribonucleic Acid)IBA
01/2018 - 12/2013
2Protein Isoforms (Isoforms)IBA
12/2017 - 12/2016
2Pyruvate KinaseIBA
12/2017 - 12/2016
2Staphylococcal Protein A (Protein A)IBA
12/2016 - 05/2007
2AcidsIBA
11/2016 - 09/2014
2Apoptosis Inducing FactorIBA
11/2016 - 11/2015
2LipidsIBA
11/2016 - 11/2015
2PolymersIBA
01/2016 - 01/2009
23-hydroxybutyrate methyl esterIBA
09/2014 - 10/2013
2S 27IBA
12/2013 - 06/2012
2Ribosomal Proteins (Ribosomal Protein)IBA
12/2013 - 06/2012
2Glucose (Dextrose)FDA LinkGeneric
10/2013 - 03/2006
2adenanthinIBA
09/2013 - 04/2012
2ElementsIBA
05/2013 - 08/2009
2Cadherins (E-Cadherin)IBA
03/2013 - 01/2012
2PeroxiredoxinsIBA
01/2013 - 04/2012
2Galectin 1 (LGALS1)IBA
10/2011 - 08/2010
2Hypoxia-Inducible Factor 1IBA
10/2011 - 06/2006
2Peptide Hydrolases (Proteases)FDA Link
10/2011 - 08/2010
2Indicators and Reagents (Reagents)IBA
07/2011 - 10/2009
2Telomerase (Telomerase Reverse Transcriptase)IBA
04/2011 - 07/2006
2Biomarkers (Surrogate Marker)IBA
02/2011 - 01/2005
2Oncogene Proteins (Oncogene Protein)IBA
01/2011 - 12/2004
2Connexin 43 (Connexin43)IBA
12/2010 - 05/2007
2Paclitaxel (Taxol)FDA LinkGeneric
01/2010 - 08/2007
2microthane foamIBA
09/2009 - 01/2009
2Urethane (Ethyl Carbamate)IBA
09/2009 - 01/2009

Therapy/Procedure

12Therapeutics
06/2022 - 05/2002
5Drug Therapy (Chemotherapy)
01/2019 - 04/2003
3Transplantation
01/2018 - 06/2014
3Lasers (Laser)
10/2008 - 01/2005
2Ligation
02/2010 - 08/2009